1. Home
  2. ONBPO vs YDESW Comparison

ONBPO vs YDESW Comparison

Compare ONBPO & YDESW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Old National Bancorp

ONBPO

Old National Bancorp

N/A

Current Price

$23.29

Market Cap

0.0

Sector

Finance

ML Signal

N/A

Logo YD Bio Limited Warrants

YDESW

YD Bio Limited Warrants

SELL

Current Price

$0.51

Market Cap

0.0

Sector

N/A

ML Signal

SELL

Company Overview

Basic Information
Metric
ONBPO
YDESW
Founded
N/A
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Sector
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
N/A
N/A
IPO Year
2012
2024

Fundamental Metrics

Financial Performance
Metric
ONBPO
YDESW
Price
$23.29
$0.51
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 5.2K
4.9K
Earning Date
N/A
N/A
Dividend Yield
N/A
N/A
EPS Growth
★ 6.55
N/A
EPS
★ 1.90
N/A
Revenue
★ $125,616,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$12.53
★ N/A
Revenue Growth
★ 6.07
N/A
52 Week Low
$23.80
$0.19
52 Week High
$25.43
$1.80

Technical Indicators

Market Signals
Indicator
ONBPO
YDESW
Relative Strength Index (RSI) 23.56 46.85
Support Level N/A $0.38
Resistance Level $25.18 $0.80
Average True Range (ATR) 0.30 0.07
MACD -0.14 -0.01
Stochastic Oscillator 26.88 34.96

Price Performance

Historical Comparison
ONBPO
YDESW

About ONBPO Old National Bancorp

Old National Bancorp is a provider of lending and deposit services. The bank offers comprehensive wealth management, trust, investment advisory, brokerage, and foreign currency services. For businesses, it provides treasury management, merchant, and capital markets services as well as community development lending and equity investment solutions intended to produce jobs and revitalize its communities. It earns interest income on loans as well as fee income from the origination of loans and from providing other services to its clients.

About YDESW YD Bio Limited Warrants

YD Bio Ltd is a biotechnology company focused on regulated diagnostics, life science clinical services and healthcare product commercialization. Its operations include DNA methylation-based oncology testing programs in the United States under an LDT framework with CLIA-certified and CAP-accredited laboratory partners. The Company also provides life science distribution and clinical trial supply chain services, including procurement, logistics coordination and compliance-focused support for clinical development programs. It maintains ocular health product commercialization operations in the United States and consumer healthcare distribution activities in Asia. The Company operates in the United States and Taiwan, with Taiwan generating maximum revenue.

Share on Social Networks: